The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-Alcoholic Steatohepatitis (NASH)

被引：0
|
作者：
Drescher, Hannah [1 ]
Weiskirchen, Ralf [2 ]
Tolba, Rene [3 ,4 ]
Trautwein, Christian [1 ]
Kroy, Daniela [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, Aachen, Germany
[2] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Cleveland, OH USA
[3] Rhein Westfal TH Aachen, Univ Hosp, Inst Lab Anim Sci & Expt Surg, Cleveland, OH USA
[4] Rhein Westfal TH Aachen, Univ Hosp, Cent Lab Lab Anim Sci, Cleveland, OH USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1816
引用
收藏
页码：1031A / 1031A
页数：1
相关论文
共 50 条
  • [1] The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)
    Drescher, Hannah K.
    Weiskirchen, Ralf
    Fueloep, Annabelle
    Hopf, Carsten
    de San Roman, Estibaliz Gonzalez
    Huesgen, Pitter F.
    de Bruin, Alain
    Bongiovanni, Laura
    Christ, Annette
    Tolba, Rene
    Trautwein, Christian
    Kroy, Daniela C.
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [2] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [3] Non-alcoholic steatohepatitis (NASH)
    Michael F. Sorrell
    Sandeep Mukherjee
    Current Treatment Options in Gastroenterology, 1999, 2 (6) : 447 - 450
  • [4] A mouse model for Non-alcoholic Steatohepatitis
    Sundaresan, Sinju
    Vijayagopal, Parakat
    Mills, Nathaniel
    Imrhan, Victorine
    Prasad, Chandan
    FASEB JOURNAL, 2010, 24
  • [5] Molecular mechanisms of fibrosis progression in non-alcoholic steatohepatitis (NASH)
    Hellerbrand, C.
    LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT, 2008, 162 : 75 - +
  • [6] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
    Liu C.-H.
    Habig G.
    Smaltz C.
    Halegoua-DeMarzio D.
    Current Hepatology Reports, 2021, 20 (4) : 117 - 127
  • [7] Therapies in non-alcoholic steatohepatitis (NASH)
    Oseini, Abdul M.
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2017, 37 : 97 - 103
  • [8] Study of development of an experimental non-alcoholic steatohepatitis (NASH) model in mice
    Morizumi, Kousuke
    Ushijima, Souta
    Oshikata, Takafumi
    Atai, Hiroshi
    Hamamura, Masao
    Nishi, Katsuhide
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 266P - 266P
  • [9] Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
    Stefano, J. T.
    Pereira, I. V. A.
    Torres, M. M.
    Bida, P. M.
    Coelho, A. M. M.
    Xerfan, M. P.
    Cogliati, B.
    Barbeiro, D. F.
    Mazo, D. F. C.
    Kubrusly, M. S.
    D'Albuquerque, L. A. C.
    Souza, H. P.
    Carrilho, F. J.
    Oliveira, C. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (05) : 408 - 414
  • [10] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Younossi, Zobair M.
    Page, Sandra
    Rafiq, Nila
    Birerdinc, Aybike
    Stepanova, Maria
    Hossain, Noreen
    Afendy, Arian
    Younoszai, Zahra
    Goodman, Zachary
    Baranova, Ancha
    OBESITY SURGERY, 2011, 21 (04) : 431 - 439
12345